Pamidronate
Links shared publicly online about this topic
Pamidronate versus observation in asymptomatic mye... [Leuk Lymphoma. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on February 10, 2011 at 3:18 pm By:
Robert Z. Orlowski Physician, Doctor, and Internist
New study: Pamidronate reduces skeletal events, but doesn't delay progression from smoldering to symptomatic myeloma (http://bit.ly/fkdDsf).
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial : The Lancet Oncology
thelancet.com — “Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial. By - Dr Pe...” View full resource at thelancet.com
Most Recently Shared on September 21, 2010 at 9:20 am By:
Nordic Myeloma Study Group compare two doses of intravenous pamidronate in patients with symptomatic myeloma http://bit.ly/d3JObw #Oncology
Risk of Skeletal-Related Events in Patients with Advanced Prostate Cancer Treated with Pamidronate or Zoledronic Acid(September) -- Spence et al., 10.1345/aph.1P152 -- The Annals of Pharmacotherapy
theannals.com — “Risk of Skeletal-Related Events in Patients with Advanced Prostate Cancer Treated with Pamidronate or Zoledronic Acid(September) -- Spence et al., 10.1345/aph.1P152 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on August 4, 2010 at 3:51 am By:
Risk of Skeletal-Related Events in Patients with Advanced Prostate Cancer Treated with Pamidronate or Zoledronic A... http://bit.ly/95KIXh
Family Medicine Article | Ankylosing spondylitis
mdlinx.com — “Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial” View full resource at mdlinx.com
Most Recently Shared on December 29, 2010 at 3:53 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial: Sin... http://bit.ly/gGRu3u #FamPractice
Endocrinology Article | Osteogenesis Imperfecta
mdlinx.com — “Intravenous Pamidronate Treatment Improves Growth in Prepubertal Osteogenesis Imperfecta Patients” View full resource at mdlinx.com
Most Recently Shared on May 4, 2011 at 2:14 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Intravenous Pamidronate Treatment Improves Growth in Prepubertal Osteogenesis Imperfecta Patients: Hormone... http://bit.ly/imoZdk #endo
Rheumatology Medical News about Bone Diseases, Metabolic Transplants
mdlinx.com — “Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant” View full resource at mdlinx.com
Most Recently Shared on March 18, 2010 at 11:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
#Rheumatology Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal tra... http://bit.ly/dj5Ddy
Oncology Medical News about Carcinoma, Non-Small-Cell Lung
mdlinx.com — “Routine use of pamidronate in NSCLC patients with bone metastasis: Results from a retrospective analysis” View full resource at mdlinx.com
Most Recently Shared on January 8, 2010 at 9:41 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Heme/Onc: Routine use of pamidronate in NSCLC patients with bone metastasis: Results from a retrospective analysis: Ant http://url4.eu/14jgO
Oncology News & Articles - MDLinx - Multiple Myeloma on #MDlinx
mdlinx.com — “Oncology News & Articles - MDLinx - Multiple Myeloma on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 23, 2010 at 6:32 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple m... http://bit.ly/aapBuk #oncology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Robert Z. Orlowski
Director of Myeloma Section at M. D. Anderson Cancer Center; Translational researcher who hates myeloma
-
The Lancet
Welcome to the Lancet.com on Twitter. Keep in touch with The Lancet, the world's leading general medical journal.
-
The Annals
The Annals of Pharmacotherapy is a peer-reviewed medical journal advancing drug therapy by publishing evidence-based pharmacy research and clinical reviews.
Advertisement
